Trials / Completed
CompletedNCT00180050
Budesonide Treatment for Lymphocytic Colitis
Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Technische Universität Dresden · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Detailed description
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide |
Timeline
- Start date
- 2002-01-01
- Primary completion
- 2006-08-01
- Completion
- 2007-08-01
- First posted
- 2005-09-16
- Last updated
- 2010-03-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00180050. Inclusion in this directory is not an endorsement.